LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Halo Therapeutics LLC
Headquarters:
Newton, MA, United States
Website:
N/A
Year Founded:
2011
Status:
Merged
BioCentury
|
Jul 29, 2013
Clinical News
HT-100: Phase Ib/IIa started
Read More
BioCentury
|
Jun 3, 2013
Product Development
The DMD landscape
Looking beyond the first Duchenne muscular dystrophy therapies
Read More
BioCentury
|
Mar 11, 2013
Product Development
Neomics' new tricks
Neomics targets new functions of aminoacyl tRNA synthetases for cancer
Read More
BioCentury
|
May 28, 2012
Company News
Halo Therapeutics musculoskeletal news
Read More
BioCentury
|
May 14, 2012
Clinical News
Halofuginone regulatory update
Read More
BioCentury
|
Mar 15, 2012
Targets & Mechanisms
Halofuginone target ID
Read More
BioCentury
|
Mar 8, 2012
Distillery Therapeutics
Indication: Autoimmune Disease
Read More
BioCentury
|
Mar 8, 2012
Distillery Therapeutics
Indication: Musculoskeletal disease
Read More
BioCentury
|
Feb 13, 2012
Emerging Company Profile
Halo: Treating DMD symptoms
Halo targeting Duchenne Muscular Dystrophy with patient group funding
Read More
BioCentury
|
Jan 9, 2012
Company News
Collgard Biopharmaceuticals Inc., Halo Therapeutics deal
Read More
Items per page:
10
1 - 10 of 11
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help